Dong, N.; Moreno-Manuel, A.; Calabuig-Fariñas, S.; Gallach, S.; Zhang, F.; Blasco, A.; Aparisi, F.; Meri-Abad, M.; Guijarro, R.; Sirera, R.;
et al. Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients. Cancers 2021, 13, 2950.
https://doi.org/10.3390/cancers13122950
AMA Style
Dong N, Moreno-Manuel A, Calabuig-Fariñas S, Gallach S, Zhang F, Blasco A, Aparisi F, Meri-Abad M, Guijarro R, Sirera R,
et al. Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients. Cancers. 2021; 13(12):2950.
https://doi.org/10.3390/cancers13122950
Chicago/Turabian Style
Dong, Ning, Andrea Moreno-Manuel, Silvia Calabuig-Fariñas, Sandra Gallach, Feiyu Zhang, Ana Blasco, Francisco Aparisi, Marina Meri-Abad, Ricardo Guijarro, Rafael Sirera,
and et al. 2021. "Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients" Cancers 13, no. 12: 2950.
https://doi.org/10.3390/cancers13122950
APA Style
Dong, N., Moreno-Manuel, A., Calabuig-Fariñas, S., Gallach, S., Zhang, F., Blasco, A., Aparisi, F., Meri-Abad, M., Guijarro, R., Sirera, R., Camps, C., & Jantus-Lewintre, E.
(2021). Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients. Cancers, 13(12), 2950.
https://doi.org/10.3390/cancers13122950
